Member Info for Wilson63

Boonboon I'd read the "unwind" paragraph but Tks for explaining to a Neanderthal, continued hold here. Gla.

Https://novacyt.com/wp-content/uploads/2022/06/Novacyt-DHSC-dispute-update-.pdf

OG it doesn't matter how many times you ask there aren't documents in the public domain, the company have stated on numerous occasions that they have strong contractual rights.

Therefore it's only things like 6 approved cdta products etc that give some on here the confidence to hold their position.

Pebble agreed and appreciated, however an alternative would be excellent.

Exmex's stuff

https://www.desmaraisllp.com/Desmarais-Secures-272M-Verdict-Prenatal-Genetic-Testing-Trial

This one is premium but headline helps

Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court

https://www.reuters.com/legal/litigation/quest-faces-next-ravgen-dna-testing-patent-trial-after-272-mln-labcorp-verdict-2022-09-26/

Tks Exmex play nice everybody information sharing is always best helps us little guys and gals sometimes buck the system.

Come on CS less of the Spanish I'm having enough problems with it cropping up in blood meridian, we could have got an experienced ceo like say Lyn Rees!!! so you never know, like we will never know what constraints David Allmond had to work under.

You said

"However let's hope it has all worked for the best and we now have a better portfolio "

I think we have before the ygen takeover(presumption).

Regarding the dispute it's difficult to find any other info other than Novacyt believe the dhsc are basing their case on incomplete data(Novacyt say) if this is accurate they are going to get chased by a Judge of any standing.

Novacyt neglected to update a lot of their other tests during covid whos to blame a combination of Graham Mullis and James Wakefield in my humble opinion. they are well through the updating process now however you only hear about it when the quality researchers post information that's because of Novacys deliberate (again imho) lack of information to markets and shareholders.

On the other hand the board are t that daft if they've purchase ygen at a price that is lower a)cheap enough to keep us happy

B) sufficient to keep ygen board and major institutions on board

C)Sufficient (the additional 6 mil payment) to as yet deter any other buyers.

Combined revenues of 27 mil this year and increasing only the ygen part of that by 20 per cent(is that correct) goes to 31 mil minimum next year although as we are well through the process of launching "very disruptive " products that's a James Mcarthy statement I'd assume revenues will be higher.

A win in the course case and we will be in an exceptional position going forward.

Appointment of dynamic CEO is crucial again imho.

Hope some of that helps Davand, let's all keep it constructive the invested will be all the happier whoever we are.

Mr big just a year out :)))

That's how I read it Kaeren

Text

"A single antibody (RSV-199) recognizes a conserved epitope in the viral glycoprotein of two viruses, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). The antibody neutralizes both viruses in vitro with broad activity against multiple strains, and also confers protection to animals challenged with the viruses using an in vivo model of infection (cotton rats)"

i land in cyprus and this:)))))off to bar for a beer/****tail/beer/swim/beer

better than an agm anyday;)))

The text from kaerens link

Interest in our Co-Prep® ES is growing.

This system is engineered to perform small scale automated extractions, saving you time when compared to manual workflows.

Discover more about Co-Prep ES, and how automation can support your #LaboratoryDiagnostics workflows.

Get in touch today: https://ow.ly/a5uY50PoFle

#Automation #COVID19Testing #LaboratoryEfficiency

1,150,000 pse.

Simmulla, through the likes of katalyst potentially. 160 by 2025 is the ambition.

https://www.gov.uk/government/news/7-new-community-diagnostic-centres-to-offer-more-patients-life-saving-checks

Page 114(and I've scan read as I'm on phone) 5.22 refers to our contract without any obvious comment and below appears to give some general outline I'm having a break though.

Gizmo the papers haven't been looking favourably at the govt. position on many things I'd also believe the judge being an expert in this field would hopefully assist Anyway revisit this document

https://www.bivda.org.uk/Portals/0/documents/Reports/COVID%20Test%20Procurement%20Paper%20Final%205.5.23.pdf?ver=2023-05-15-082323-987#page39

Contracts awarded page 58 we are first listed page page 63 and I'm going to wade through from there(it's been well covered but perhaps fresh eyes can glean something from it.

My regret is we are not also chasing them for the 30+ mil that we used to buy materials we purchased in advance.

CS I was at this gig in 78 never realised it was recorded Jobson wanted to fight as he was getting spat on by the hardcore punks at the front.

https://soundcloud.com/scottish-post-punk/sets/skids-live-at-tiffanys-edinburgh-1978

Evening all , you do know it's holiday season and many are out enjoying the sun!!!! in kagouls and wellies.

Gizmo some people may just want to know if their unborn child has a condition to be prepared, others will also choose termination as is the choice in our society (glad I've never been in that position)

I've asked Davands opinion in the past and appreciated the reply but there is plenty of reading on iona nipt .

I'm off to listen to the skids(hands up who remembers)version of iona in fairness an acquired taste.

Tks to Larry for posting on twitter for those that can't read twitter Dr Thomas heister our European sales manager says "I am happy to announce the offical partnership with #SUPERLAB in Belgrade Serbia, which will drive sales & distribution of #Novacyt’s products in Serbia, Bosnia, Macedonia, Montenegro as well as Kosovo.

In our meeting last week we completed a full product training, discussed the strategic plan for rest of 2023 and visited some end-user customers to introduce our Novacyt complete workflow solutions. We had great customers feedback, excellent exchange with our SUPERLAB colleagues and despite nearly 40°C also a little bit fun. Thanks to Jelena Paunović, Aleksandar Dimitrijević, Jovan Trbojević, Aleksandar Nesic and all others we met, for the open and furitful exchange as well as the impressive tour through #InsititutSUPERLAB. I am looking forward to a very successful long-term cooperation with SUPERLAB and to seeing you again soon."

Back to the beverages.